ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,534,358 | +4.1% | 94,422 | +18.4% | 0.00% | +100.0% |
| Q1 2024 | $1,474,060 | -52.1% | 79,722 | -18.9% | 0.00% | -66.7% |
| Q4 2023 | $3,079,432 | +48.4% | 98,353 | -1.2% | 0.00% | +50.0% |
| Q3 2023 | $2,074,935 | +10.8% | 99,565 | +27.4% | 0.00% | 0.0% |
| Q2 2023 | $1,872,195 | +26.6% | 78,171 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $1,478,876 | +26.3% | 78,580 | +6.8% | 0.00% | +100.0% |
| Q4 2022 | $1,170,884 | +296.9% | 73,548 | +308.4% | 0.00% | – |
| Q3 2022 | $295,000 | +13.9% | 18,009 | -2.0% | 0.00% | – |
| Q2 2022 | $259,000 | -22.7% | 18,369 | +1.0% | 0.00% | – |
| Q1 2022 | $335,000 | -22.3% | 18,189 | -1.5% | 0.00% | – |
| Q4 2021 | $431,000 | +36.4% | 18,475 | -2.9% | 0.00% | – |
| Q3 2021 | $316,000 | -38.9% | 19,036 | -10.2% | 0.00% | – |
| Q2 2021 | $517,000 | -12.4% | 21,202 | -7.3% | 0.00% | -100.0% |
| Q1 2021 | $590,000 | -48.8% | 22,874 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $1,153,000 | +19.2% | 21,572 | -7.9% | 0.00% | 0.0% |
| Q3 2020 | $967,000 | -12.1% | 23,434 | +3.2% | 0.00% | 0.0% |
| Q2 2020 | $1,100,000 | -42.6% | 22,703 | -50.0% | 0.00% | -50.0% |
| Q1 2020 | $1,918,000 | +97.5% | 45,416 | +100.2% | 0.00% | +100.0% |
| Q4 2019 | $971,000 | +40.5% | 22,688 | +18.1% | 0.00% | 0.0% |
| Q3 2019 | $691,000 | +8537.5% | 19,209 | +3644.4% | 0.00% | – |
| Q2 2018 | $8,000 | -33.3% | 513 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | -20.0% | 513 | 0.0% | 0.00% | – |
| Q4 2017 | $15,000 | -21.1% | 513 | 0.0% | 0.00% | – |
| Q3 2017 | $19,000 | +35.7% | 513 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | -17.6% | 513 | +1.8% | 0.00% | – |
| Q1 2017 | $17,000 | +13.3% | 504 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | 0.0% | 504 | +5.9% | 0.00% | – |
| Q3 2016 | $15,000 | +7.1% | 476 | +7.4% | 0.00% | – |
| Q2 2016 | $14,000 | +16.7% | 443 | +2.1% | 0.00% | – |
| Q1 2016 | $12,000 | -14.3% | 434 | +8.0% | 0.00% | – |
| Q4 2015 | $14,000 | +7.7% | 402 | +6.1% | 0.00% | – |
| Q3 2015 | $13,000 | -13.3% | 379 | +8.9% | 0.00% | – |
| Q2 2015 | $15,000 | – | 348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |